Meet The Professors: Volume 1 Issue 1
A case-based discussion on the management
of lung cancer in the adjuvant and
metastatic settings
Faculty: |
|||
Martin J Edelman, MD | Alan B Sandler, MD | ||
Thomas J Lynch, MD | Mark A Socinski, MD |
FACULTY AFFILIATIONS AND DISCLOSURES Case Studies Case 1: An active 78-year-old woman with adenocarcinoma and bronchoalveolar features (from the practice of Dr William G Reeves) Case 2: A 69-year-old woman with metastatic, poorly differentiated adenocarcinoma and a four-year response to six cycles of adjuvant carboplatin/paclitaxel (from the practice of Dr Atif M Hussein) Case 3: A prior oligosmoker in her sixties, diagnosed with Stage IV adenocarcinoma, who enrolled in CALGB-30406 and was assigned to treatment with carboplatin/paclitaxel/erlotinib (from the practice of Dr Mark A Taylor) Case 4: A 65-year-old woman with Stage IIIB multifocal bronchoalveolar carcinoma (from the practice of Dr Howard R Abel) Case 5: A 68-year-old female nonsmoker with recurrent pleural effusions secondary to metastatic non-small cell lung cancer (NSCLC) (from the practice of Dr Kert D Sabbath) Case 6: An 85-year-old woman with a performance status of 1-2 and Stage IIIB adenocarcinoma (from the practice of Dr Noor M Merchant) Case 7: A 61-year-old female nonsmoker with Stage IV NSCLC (from the practice of Dr Noor M Merchant) Case 8: An asymptomatic 58-year-old female nonsmoker with brain metastases secondary to adenocarcinoma (from the practice of Dr Samuel N Bobrow) Case 9: A 64-year-old man s/p lobectomy for a four-centimeter Stage IB adenocarcinoma (from the practice of Dr Samuel N Bobrow) Case 10: A 45-year-old female nonsmoker with Stage IIIB adenocarcinoma and palpable supraclavicular adenopathy (from the practice of Dr Paul L Weinstein) |
Terms of Use and General Disclaimer | Privacy Policy | Hardware/Software Requirements Copyright © 2006 Research To Practice. All Rights Reserved |